Doug Treco, Ph.D.
Advisor at Lightstone Ventures
About
Advisor to Lightstone Ventures and co-founder of Ra Pharmaceuticals, serving as CEO until its 2020 acquisition by UCB. Doug also co-founded Transkaryotic Therapies (acquired by Shire in 2005) and served as Entrepreneur-in-Residence at Morgenthaler Ventures.
Colleagues at Lightstone Ventures
Caroline Gaynor
Partner at Lightstone Ventures
Christina Isacson, Ph.D.
Partner at Lightstone Ventures
Frank D. Lee
Advisor at Lightstone Ventures
H. Martin Seidel, Ph.D.
Advisor at Lightstone Ventures
Hank Plain
Founding Partner & Advisor at Lightstone Ventures
Hanson S. Gifford, III
Partner at Lightstone Ventures
Hong I. Wan, Ph.D.
Advisor at Lightstone Ventures
Jean George
Managing Partner at Lightstone Ventures